1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEUROCRINE BIOSCIENCES, INC.
Neurocrine Biosciences, Inc. XNAS: NBIX

Neurocrine Biosciences, Inc. Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive ...

Read More
140.09 2.57 (1.87%)
66.32% Gain from 52W Low
977.2K
XNAS Volume

XNAS 17 Oct, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Neurocrine Biosciences, Inc. is on 28 Oct 2025 for the purpose of Neurocrine Biosciences Inc Third Quarter Earnings Conference Call for 2025 See details
Durability score
Medium Financial Strength
44.4 / 100
Valuation Score
Mid Valuation
36.0 / 100
Momentum Score
Technically Neutral
50.6 / 100
Mid-range Performer These stocks average quality, financial and technical aspects make them being considered by the investor who are not looking for high risk stocks. View Similar Embed DVM
Analyst Price Target
169
1Yr Price target upside is 21%
26 analysts

19

S

7

W

5

O

2

T

SWOT Analysis

Neurocrine Biosciences Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..